9
|
Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, Chen MB, Krall JA, DeCock J, Zervantonakis IK, Iannello A, Iwamoto Y, Cortez-Retamozo V, Kamm RD, Pittet MJ, Raulet DH, Weinberg RA. Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. Cancer Discov 2016; 6:630-49. [PMID: 27072748 DOI: 10.1158/2159-8290.cd-15-1157] [Citation(s) in RCA: 337] [Impact Index Per Article: 42.1] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2015] [Accepted: 04/04/2016] [Indexed: 12/17/2022]
Abstract
UNLABELLED Immune cells promote the initial metastatic dissemination of carcinoma cells from primary tumors. In contrast to their well-studied functions in the initial stages of metastasis, the specific roles of immunocytes in facilitating progression through the critical later steps of the invasion-metastasis cascade remain poorly understood. Here, we define novel functions of neutrophils in promoting intraluminal survival and extravasation at sites of metastatic dissemination. We show that CD11b(+)/Ly6G(+) neutrophils enhance metastasis formation via two distinct mechanisms. First, neutrophils inhibit natural killer cell function, which leads to a significant increase in the intraluminal survival time of tumor cells. Thereafter, neutrophils operate to facilitate extravasation of tumor cells through the secretion of IL1β and matrix metalloproteinases. These results identify neutrophils as key regulators of intraluminal survival and extravasation through their cross-talk with host cells and disseminating carcinoma cells. SIGNIFICANCE This study provides important insights into the systemic contributions of neutrophils to cancer metastasis by identifying how neutrophils facilitate intermediate steps of the invasion-metastasis cascade. We demonstrate that neutrophils suppress natural killer cell activity and increase extravasation of tumor cells. Cancer Discov; 6(6); 630-49. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 561.
Collapse
Affiliation(s)
- Asaf Spiegel
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
| | - Mary W Brooks
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
| | - Samin Houshyar
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
| | - Ferenc Reinhardt
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
| | - Michele Ardolino
- Department of Molecular and Cell Biology and Cancer Research Laboratory, Division of Immunology, University of California at Berkeley, Berkeley, California
| | - Evelyn Fessler
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
| | - Michelle B Chen
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts
| | - Jordan A Krall
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
| | - Jasmine DeCock
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
| | - Ioannis K Zervantonakis
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts
| | - Alexandre Iannello
- Department of Molecular and Cell Biology and Cancer Research Laboratory, Division of Immunology, University of California at Berkeley, Berkeley, California
| | - Yoshiko Iwamoto
- Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
| | - Virna Cortez-Retamozo
- Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
| | - Roger D Kamm
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts
| | - Mikael J Pittet
- Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
| | - David H Raulet
- Department of Molecular and Cell Biology and Cancer Research Laboratory, Division of Immunology, University of California at Berkeley, Berkeley, California
| | - Robert A Weinberg
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts. Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts. Massachusetts Institute of Technology Ludwig Center for Molecular Oncology, Cambridge, Massachusetts.
| |
Collapse
|
10
|
Takahashi R, Mabuchi S, Kawano M, Sasano T, Matsumoto Y, Kuroda H, Hisamatsu T, Kozasa K, Sawada K, Hamasaki T, Kimura T. Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study. Gynecol Oncol 2015; 137:112-8. [PMID: 25680864 DOI: 10.1016/j.ygyno.2015.02.006] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2015] [Accepted: 02/04/2015] [Indexed: 11/25/2022]
Abstract
OBJECTIVE The aim of this study was to investigate the prognostic significance of an elevated neutrophil count at the time of the initial diagnosis in patients with surgically treated endometrial cancer. METHODS The baseline characteristics and outcome data of patients who were diagnosed with endometrial cancer between January 2000 and December 2010 were collected and retrospectively reviewed. The patients were separated into two groups according to their neutrophil counts. The clinicopathological characteristics and overall survival rates of the two groups were compared. A Cox proportional hazard regression model was used to investigate the prognostic significance of an elevated neutrophil count among patients with surgically treated endometrial cancer. RESULTS An elevated neutrophil count was found to be associated with an advanced clinical stage (P<0.0001), lymphovascular space involvement (P=0.0003), cervical involvement (P=0.0049), the proportion of patients that received adjuvant therapy (P=0.0020), elevated NLR (P<0.0001), and treatment failure (P<0.0001). Multivariate analyses demonstrated that age (hazard ratio (HR)=2.23, 95% confidence interval (95% CI)=1.30 to 3.91; P=0.0035), clinical stage (HR=4.72, 95% CI=2.61 to 8.90; P<0.0001), lymphovascular space involvement (HR=3.15, 95% CI=1.60 to 6.68; P=0.0007), an elevated neutrophil count (HR=2.76, 95% CI=1.43 to 5.03; P=0.0033), and an elevated white blood cell count (HR=2.79, 95% CI=1.50 to 4.96; P=0.0017) were significant predictors of survival. CONCLUSION The elevated neutrophil or leukocyte counts at the time of the initial diagnosis are independent prognostic factors in patients with surgically treated endometrial cancer.
Collapse
Affiliation(s)
- Ryoko Takahashi
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Seiji Mabuchi
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
| | - Mahiru Kawano
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Tomoyuki Sasano
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Yuri Matsumoto
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Hiromasa Kuroda
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Takeshi Hisamatsu
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Katsumi Kozasa
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Kenjiro Sawada
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Toshimitsu Hamasaki
- Department of Biomedical Statistics, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Tadashi Kimura
- Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| |
Collapse
|
12
|
Mabuchi S, Matsumoto Y, Kawano M, Minami K, Seo Y, Sasano T, Takahashi R, Kuroda H, Hisamatsu T, Kakigano A, Hayashi M, Sawada K, Hamasaki T, Morii E, Kurachi H, Matsuura N, Kimura T. Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature. J Natl Cancer Inst 2014; 106:dju147. [PMID: 24948742 DOI: 10.1093/jnci/dju147] [Citation(s) in RCA: 90] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Tumor-related leukocytosis (TRL) is occasionally found in patients with nonhematopoietic malignancies. We investigated the clinical implication of TRL and individualized treatment for TRL-positive cervical cancer, as well as the underlying biological mechanism. METHODS Clinical data from 258 cervical cancer patients treated with definitive radiotherapy were analyzed to investigate the association between TRL and treatment outcome. Clinical samples, cervical cancer cell lines, and a mouse model of cervical cancer were used to examine the mechanisms responsible for TRL in cervical cancer, focusing on the role of tumor-derived granulocyte colony-stimulating factor (G-CSF) and myeloid-derived suppressor cells (MDSCs). All statistical tests were two-sided. RESULTS TRL was statistically significantly associated with younger age (Wilcoxon rank sum test, P = .03), larger tumor size (Wilcoxon rank sum test, P = .006), advanced clinical stage (χ(2) test, P = .01), and shorter overall survival (Cox proportional hazard modeling and Wald tests, P < .001). Among cervical cancer patients, TRL was associated with upregulated tumor G-CSF expression (χ(2) test, P < .001), elevated serum G-CSF levels (Student t test, P = .03), larger spleens (Student t test, P = .045), and increased MDSC frequencies in the blood (Student t test, P < .001) compared with the TRL-negative patients. In vitro and in vivo experiments revealed that tumor-derived G-CSF was involved in the underlying causative mechanism of TRL and MDSCs induced by tumor-derived G-CSF are responsible for the rapidly progressive and radioresistant nature of TRL-positive cervical cancer. The administration of anti-Gr-1 neutralizing antibody or the depletion of MDSCs by splenectomy (n = 6 per group) inhibited tumor growth and enhanced radiosensitivity in TRL-positive cervical cancer xenografts (Wilcoxon rank sum test, P = .008 and P = .02, respectively). CONCLUSIONS TRL is associated with resistance to radiotherapy among cervical cancer patients, and MDSC-targeting treatments may have therapeutic potential in these patients.
Collapse
Affiliation(s)
- Seiji Mabuchi
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK).
| | - Yuri Matsumoto
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Mahiru Kawano
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Kazumasa Minami
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Yuji Seo
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Tomoyuki Sasano
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Ryoko Takahashi
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Hiromasa Kuroda
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Takeshi Hisamatsu
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Aiko Kakigano
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Masami Hayashi
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Kenjiro Sawada
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Toshimitsu Hamasaki
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Eiichi Morii
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Hirohisa Kurachi
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Nariaki Matsuura
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| | - Tadashi Kimura
- Affiliations of authors: Department of Obstetrics and Gynecology (SM, YM, MK, TS, RT, HK, TH, AK, KS, TK), Department of Molecular Pathology (KM, NM), Department of Radiation Oncology (YS), Department of Biomedical Statistics (TH), and Department of Pathology (EM), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan (MH); Department of Obstetrics and Gynecology, Yamagata University Graduate School of Medicine, Yamagata, Japan (HK)
| |
Collapse
|